Mystery in 5 acts. Mol Cell. 2011; 44:9?6. [PubMed: 21981915] 13. Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol. 2008; 9:378?90. [PubMed: 18414491] 14. Mahr JA, Gooding LR. Immune evasion by adenoviruses. Immunol Rev. 1999; 168:121?30. [PubMed: 10399069] 15. Rahman MM, McFadden G. Modulation of tumor necrosis aspect by microbial pathogens. PLoS Pathog. 2006; two:e4. [PubMed: 16518473] 16. McCormick, AL.; Mocarski, ES. Cell death pathways controlled by cytomegaloviruses. In: Reddehase, MJ., editor. Cytomegaloviruses: From Molecular Pathogenesis to Intervention. Caister Scientific Press; Norfolk, Uk: 2013. p. 263-276. 17. Domm S, Cinatl J, Mrowietz U. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a assessment with the literature. Br J Dermatol. 2008; 159:1217?228. [PubMed: 18945310] 18. Bousfiha A, Picard C, Boisson-Dupuis S, Zhang SY, Bustamante J, Puel A, Jouanguy E, Ailal F, El-Baghdadi J, Abel L, Casanova JL. Principal immunodeficiencies of protective immunity to major infections. Clin Immunol. 2010; 135:204?09. [PubMed: 20236864]J Immunol. Author manuscript; offered in PMC 2015 March 01.Mocarski et al.Page19. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.1H-Pyrrolo[2,3-b]pyridin-4-amine Data Sheet Cell. 2003; 114:181?90. [PubMed: 12887920] 20. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS, Green DR. Catalytic activity with the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature. 2011; 471:363?67. 21. Dillon CP, Oberst A, Weinlich R, Janke LJ, Kang TB, Ben-Moshe T, Mak TW, Wallach D, Green DR. Survival function of your FADD-Caspase-8-cFLIP(L) complicated. Cell Rep. 2012; 1:401?07. [PubMed: 22675671] 22. Degterev A, Hitomi J, Germscheid M, Ch’en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J.Price of 1783624-20-3 Identification of RIP1 kinase as a precise cellular target of necrostatins.PMID:23398362 Nat Chem Biol. 2008; 4:313?21. [PubMed: 18408713] 23. Benedict CA, Banks TA, Ware CF. Death and survival: viral regulation of TNF signaling pathways. Curr Opin Immunol. 2003; 15:59?5. [PubMed: 12495734] 24. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J. Chemical inhibitor of nonapoptotic cell death with therapeutic prospective for ischemic brain injury. Nat Chem Biol. 2005; 1:112?19. [PubMed: 16408008] 25. Upton JW, Kaiser WJ, Mocarski ES. DAI (ZBP1/DLM-1) complexes with RIP3 to mediate virusinduced programmed necrosis that is definitely targeted by murine cytomegalovirus vIRA. Cell Host Microbe. 2012; 11:290?97. [PubMed: 22423968] 26. Upton JW, Kaiser WJ, Mocarski ES. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe. 2010; 7:302?13. [PubMed: 20413098] 27. He S, Liang Y, Shao F, Wang X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci U S A. 2011; 108:20054?0059. [PubMed: 22123964] 28. Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, Sehon CA, Marquis RW, Bertin J, Mocarski ES. Toll-like Receptor 3-mediated necrosis by means of TRIF, RIP3 and MLKL. J Biol Chem. 2013; 288:31268?1279. [PubMed: 24019532] 29. Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S. Form I interferon induces necroptosis in macrophages through infection with Salmonella enterica serovar Typhim.